Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2019 | Aug. 14, 2019 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | Trident Acquisitions Corp. | |
Entity Central Index Key | 0001673481 | |
Document Type | 10-Q | |
Document Period End Date | Jun. 30, 2019 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2019 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Entity's Reporting Status Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Emerging Growth Company | true | |
Entity Small Business | true | |
Entity Shell Company | true | |
Entity Ex Transition Period | false | |
Entity Common Stock, Shares Outstanding | 26,306,250 | |
Entity File Number | 001-38508 | |
Entity Interactive Data Current | Yes | |
Entity Incorporation State Country Code | DE |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Jun. 30, 2019 | Dec. 31, 2018 |
Current Assets | ||
Cash | $ 351,228 | $ 1,255,817 |
Cash held in escrow | 386,030 | |
Prepaid expenses | 83,270 | 63,843 |
Total Current Assets | 820,528 | 1,319,660 |
Marketable securities held in Trust Account | 209,878,786 | 207,753,062 |
Security deposit | 1,200 | 1,200 |
Total Assets | 210,700,514 | 209,073,922 |
Current Liabilities | ||
Account payable and accrued expenses | 80,952 | 159,512 |
Income taxes payable | 425,899 | 373,794 |
Promissory note - related party | 425,000 | 425,000 |
Total Current Liabilities | 931,851 | 958,306 |
Deferred tax liability | 31,606 | 851 |
Deferred underwriting fee payable | 5,031,250 | 5,031,250 |
Total Liabilities | 5,994,707 | 5,990,407 |
Commitments | ||
Common stock subject to possible redemption, 19,193,198 and 19,235,623 shares at redemption value as of June 30, 2019 and December 31, 2018, respectively | 199,705,803 | 198,083,507 |
Stockholders' Equity | ||
Common stock, $0.001 par value; 100,000,000 shares authorized; 7,113,052 and 7,070,627 issued and outstanding (excluding 19,193,198 and 19,235,623 shares subject to possible redemption) as of June 30, 2019 and December 31, 2018, respectively | 7,113 | 7,071 |
Additional paid-in capital | 1,968,874 | 3,591,212 |
Retained earnings | 3,024,017 | 1,401,725 |
Total Stockholders' Equity | 5,000,004 | 5,000,008 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 210,700,514 | $ 209,073,922 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Jun. 30, 2019 | Dec. 31, 2018 |
Statement of Financial Position [Abstract] | ||
Common stock subject to possible redemption | 19,193,198 | 19,235,623 |
Common stock (in dollars per shares) | $ 0.001 | $ 0.001 |
Common stock authorized | 100,000,000 | 100,000,000 |
Common stock issued | 7,113,052 | 7,070,627 |
Common stock outstanding | 7,113,052 | 7,070,627 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 | ||
Income Statement [Abstract] | |||||
Operating costs | $ 313,480 | $ 155,407 | $ 539,697 | $ 160,135 | |
Loss from operations | (313,480) | (155,407) | (539,697) | (160,135) | |
Other income: | |||||
Interest income | 1,248,225 | 286,467 | 2,480,374 | 286,467 | |
Unrealized gain (loss) on marketable securities held in Trust Account | 134,335 | (8,412) | 150,505 | (8,412) | |
Other income, net | 1,382,560 | 278,055 | 2,630,879 | 278,055 | |
Income before provision for income taxes | 1,069,080 | 122,648 | 2,091,182 | 117,920 | |
Provision for income taxes | (241,603) | (24,763) | (468,890) | (24,763) | |
Net income | $ 827,477 | $ 97,885 | $ 1,622,292 | $ 93,157 | |
Weighted average shares outstanding, basic and diluted | [1] | 7,083,746 | 5,191,749 | 7,077,223 | 4,449,995 |
Basic and diluted net loss per common share | [2] | $ (0.03) | $ (0.02) | $ (0.05) | $ (0.02) |
[1] | Excludes an aggregate of 19,193,198 and 19,272,344 shares subject to redemption, at June 30, 2019 and 2018, respectively. | ||||
[2] | Net loss per share - basic and diluted excludes income attributable to common stock subject to possible redemption of $1,057,670, and $194,672 for the three months ended June 30, 2019 and 2018, respectively, and $1,983,743 and $194,672 for the six months ended June 30, 2019 and 2018, respectively. |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Operations (Parenthetical) - shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 | |
Income Statement [Abstract] | ||||
Excludes an aggregate of shares subject to redemption | 19,193,198 | 19,272,344 | ||
Net loss per share - basic and diluted excludes income attributable to common stock subject to possible redemption | 1,057,670 | 194,672 | 1,983,743 | 194,672 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) | Common Stock | Additional Paid-in Capital | Retained Earnings (Accumulated Deficit) | Total |
Balance at Dec. 31, 2017 | $ 3,737 | $ 21,263 | $ (2,358) | $ 22,642 |
Balance, shares at Dec. 31, 2017 | 3,737,500 | |||
Common stock issued to initial stockholders | $ 1,294 | 7,360 | 8,654 | |
Common stock issued to initial stockholders (in shares) | 1,293,750 | |||
Net income (loss) | (4,728) | (4,728) | ||
Balance at Mar. 31, 2018 | $ 5,031 | 28,623 | (7,086) | 26,568 |
Balance, shares at Mar. 31, 2018 | 5,031,250 | |||
Sale of 20,125,000 Units, net of underwriting discounts and offering expenses | $ 20,125 | 190,128,011 | 190,148,136 | |
Sale of 20,125,000 Units, net of underwriting discounts and offering expenses, shares | 20,125,000 | |||
Sale of 1,150,000 Private Units | $ 1,150 | 11,498,850 | 11,500,000 | |
Sale of 1,150,000 Private Units, shares | 1,150,000 | |||
Change in value of common stock subject to possible redemption | $ (19,272) | (196,753,316) | (196,772,588) | |
Change in value of common stock subject to possible redemption, shares | (19,273,344) | |||
Net income (loss) | 97,885 | 97,885 | ||
Balance at Jun. 30, 2018 | $ 7,034 | 4,902,168 | 90,799 | 5,000,001 |
Balance, shares at Jun. 30, 2018 | 7,032,906 | |||
Balance at Dec. 31, 2018 | $ 7,071 | 3,591,212 | 1,401,725 | 5,000,008 |
Balance, shares at Dec. 31, 2018 | 7,070,627 | |||
Change in value of common stock subject to possible redemption | $ 13 | (794,833) | (794,820) | |
Change in value of common stock subject to possible redemption, shares | 13,119 | |||
Net income (loss) | 794,815 | 794,815 | ||
Balance at Mar. 31, 2019 | $ 7,084 | 2,796,379 | 2,196,540 | 5,000,003 |
Balance, shares at Mar. 31, 2019 | 7,083,746 | |||
Change in value of common stock subject to possible redemption | $ 29 | (827,505) | (827,476) | |
Change in value of common stock subject to possible redemption, shares | 29,306 | |||
Net income (loss) | 827,477 | 827,477 | ||
Balance at Jun. 30, 2019 | $ 7,113 | $ 1,968,874 | $ 3,024,017 | $ 5,000,004 |
Balance, shares at Jun. 30, 2019 | 7,113,052 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical) | 6 Months Ended |
Jun. 30, 2018shares | |
Statement of Stockholders' Equity [Abstract] | |
Number of units sold | 20,125,000 |
Sale of private units | 1,150,000 |
Condensed Consolidated Statem_5
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
Jun. 30, 2019 | Jun. 30, 2018 | |
Cash Flows from Operating Activities: | ||
Net income | $ 1,622,292 | $ 93,157 |
Adjustments to reconcile net income to net cash used in operating activities: | ||
Interest earned on marketable securities held in Trust Account | (2,480,374) | (286,467) |
Unrealized (gain) loss on marketable securities held in Trust Account | (150,505) | 8,412 |
Deferred tax provision | 30,755 | |
Changes in operating assets and liabilities: | ||
Prepaid expenses | (19,427) | (144,645) |
Accounts payable and accrued expenses | (78,560) | 51,418 |
Income taxes payable | 52,105 | 24,763 |
Net cash and cash held in escrow used in operating activities | (1,023,714) | (253,362) |
Cash Flows from Investing Activities: | ||
Investment of cash in Trust Account | (205,275,000) | |
Cash withdrawn from Trust Account to pay for income and franchise taxes | 505,155 | |
Net cash and cash held in escrow provided by (used in) investing activities | 505,155 | (205,275,000) |
Cash Flows from Financing Activities: | ||
Proceeds from issuance of common stock to initial stockholders | 8,654 | |
Proceeds from sale of Units, net of underwriting discounts paid | 196,218,750 | |
Proceeds from sale of Private Units | 11,500,000 | |
Proceeds from promissory notes - related parties | 300,000 | |
Repayment of promissory notes - related parties | (400,000) | |
Payment of offering costs | (636,325) | |
Net cash and cash held in escrow provided by financing activities | 206,991,079 | |
Net Change in Cash and Cash Held in Escrow | (518,559) | 1,462,717 |
Cash and Cash Held in Escrow - Beginning | 1,255,817 | 143,403 |
Cash and Cash Held in Escrow - Ending | 737,258 | 1,606,120 |
Supplemental cash flow information: | ||
Cash paid for income taxes | 386,030 | |
Non-cash investing and financing activities: | ||
Initial classification of common stock subject to redemption | 196,674,614 | |
Change in value of common stock subject to possible redemption | 1,622,296 | 97,974 |
Deferred underwriting fee charged to additional paid in capital | $ 5,031,250 |
Description of Organization and
Description of Organization and Business Operations | 6 Months Ended |
Jun. 30, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Trident Acquisitions Corp. (the "Company") is a blank check company incorporated in Delaware on March 17, 2016. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses that the Company has not yet identified ("Business Combination"). The Company has one subsidiary, Trident Black Sea Inc., a majority-owned subsidiary of the Company incorporated in Delaware on May 7, 2019 ("Trident Black Sea"). At June 30, 2019, the Company had not yet commenced operations. All activity through June 30, 2019 relates to the Company's formation, its public offering ("Initial Public Offering"), which is described below, and identifying a target for a Business Combination. The registration statement for the Company's Initial Public Offering was declared effective on May 29, 2018. On June 1, 2018, the Company consummated the Initial Public Offering of 17,500,000 units ("Units" and, with respect to the common stock included in the Units being offered, the "Public Shares"), generating gross proceeds of $175,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 1,150,000 Private Units, at a price of $10.00 per unit in a private placement to certain of the Company's affiliates and stockholders (the "Insiders"), generating gross proceeds of $11,500,000, which is described in Note 4. Following the closing of the Initial Public Offering on June 1, 2018, an amount of $178,500,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Units was placed in a trust account ("Trust Account") which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "Investment Company Act"), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account, as described below. On June 5, 2018, in connection with the underwriters' exercise of their over-allotment option in full, the Company consummated the sale of an additional 2,625,000 Units at $10.00 per unit, generating total gross proceeds of $26,250,000. Simultaneously with the sale of the additional Units, the Company deposited an aggregate of $1,181,250 into the Trust Account from funds previously held outside of the Trust Account. A total of $26,775,000 was deposited in the Trust Account, bringing the aggregate proceeds held in the Trust Account to $205,275,000. Transaction costs amounted to $11,101,864, consisting of $5,031,250 of underwriting fees, $5,031,250 of deferred underwriting fees and $1,039,364 of other costs. As of June 30, 2019, $351,228 of cash was held outside of the Trust Account and was available for working capital purposes. The Company's management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq Capital Market ("NASDAQ") rules provide that the Company's initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and interest released to pay franchise and income taxes) at the time of the signing a definitive agreement in connection with a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its stockholders with the opportunity to convert all or a portion of their shares included in the Units sold in the Initial Public Offering (the "Public Shares") upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to convert their shares for a pro rata portion of the amount then in the Trust Account ($10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and incomes tax obligations).The per-share amount to be distributed to stockholders who convert their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 6). There will be no conversion rights upon the completion of a Business Combination with respect to the Company's warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the conversions pursuant to the tender offer rules of the Securities and Exchange Commission ("SEC"), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will offer to convert shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to convert their Public Shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing, the Company's Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), will be restricted from converting its shares with respect to more than an aggregate of 20% of the shares sold in the Initial Public Offering ("Excess Shares"). The Company's Insiders, officers, directors and any holder of the Company's insider shares (as defined in Note 5) (the "initial stockholders") have agreed (a) to vote their insider shares, Private Shares (as defined in Note 5) and Public Shares in favor of a Business Combination, (b) not to propose an amendment to the Company's Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company's obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their shares in conjunction with any such amendment; (c) not to convert any shares in connection with a stockholder vote to approve a Business Combination and (d) that the insider shares and Private Shares will not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. The Company will have until December 1, 2019 to consummate a Business Combination (the "Combination Period"). If the Company is unable to consummate a Business Combination within the Combination Period , the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders' rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company's board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The initial stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their insider shares and Private Shares if the Company fails to complete a Business Combination during the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive its rights to the deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company's Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the $10.20 per share held in the Trust Account. In order to protect the amounts held in the Trust Account, the initial stockholders have agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company's indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the initial stockholders will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the initial stockholders will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company's independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2019 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the SEC on March 27, 2019, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2018 is derived from the audited financial statements presented in the Company's Annual Report on Form 10-K for the year ended December 31, 2018. The interim results for the three and six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019 or for any future interim periods. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiary where the Company has the ability to exercise control. All significant intercompany balances and transactions have been eliminated in consolidation. Activities in relation to the noncontrolling interest are not considered to be significant and are, therefore, not presented in the accompanying condensed consolidated financial statements. Emerging growth company The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company's balance sheet with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2019 and December 31, 2018. Cash held in escrow At May 7, 2019, the Company placed $386,030 into an escrow account maintained by the Company's legal counsel (the "Escrowed Amount"). The Escrowed Amount is being held in a non-interest bearing account, is under the Company's full control and will be released upon written instruction from the Company. As of June 30, 2019, $386,030 of cash remained in the escrow account. Marketable securities held in Trust Account At June 30, 2019 and December 31, 2018, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the six months ended June 30, 2019, the Company withdrew $505,155 of interest earned on the Trust Account to pay its franchise and income tax obligations. Common stock subject to possible redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) is classified as temporary equity. At all other times, common stock is classified as stockholders' equity. The Company's common stock features certain redemption rights that are considered to be outside of the Company's control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders' equity section of the Company's condensed consolidated balance sheets. Income taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2019 and December 31, 2018, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company may be subject to potential examination by federal or state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. Net loss per common share Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and private placement to purchase 21,275,000 shares of common stock and (2) 1,750,000 shares of common stock and warrants to purchase 1,750,000 shares of common stock in the unit purchase option sold to the underwriters and their designees, in the calculation of diluted loss per share, since the exercise of the warrants and the exercise of the unit purchase option is contingent upon the occurrence of future events. As a result, diluted loss per common share is the same as basic loss per common share for the periods. Reconciliation of net loss per common share The Company's net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: Three Months Ended June 30, Six Months Ended June 30, 2019 2018 2019 2018 Net income $ 827,477 $ 97,885 $ 1,622,292 $ 93,157 Less: Income attributable to shares subject to redemption (1,057,670 ) (194,672 ) (1,983,743 ) (194,672 ) Adjusted net loss $ (230,193 ) $ (96,787 ) $ (361,451 ) $ (101,515 ) Weighted average common shares outstanding, basic and diluted 7,083,746 5,191,749 7,077,223 4,449,995 Basic and diluted net loss per common share $ (0.03 ) $ (0.02 ) $ (0.05 ) $ (0.02 ) Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal depository insurance coverage of $250,000. At June 30, 2019 and December 31, 2018, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair value of financial instruments The fair value of the Company's assets and liabilities, which qualify as financial instruments under ASC Topic 820, "Fair Value Measurements and Disclosures," approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature. Recently issued accounting standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company's condensed consolidated financial statements. |
Initial Public Offering
Initial Public Offering | 6 Months Ended |
Jun. 30, 2019 | |
Equity [Abstract] | |
INITIAL PUBLIC OFFERING | NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 20,125,000 Units at a purchase price of $10.00 per Unit, inclusive of 2,625,000 Units sold to the underwriters upon the underwriters' election to exercise their over-allotment option in full. Each Unit consists of one share of common stock and one warrant ("Public Warrant"). Each Public Warrant entitles the holder to purchase one share of common stock at an exercise price of $11.50 per share (see Note 7). |
Private Placement
Private Placement | 6 Months Ended |
Jun. 30, 2019 | |
Equity [Abstract] | |
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT Simultaneously with the Initial Public Offering, the Insiders purchased an aggregate of 1,150,000 Private Units, at $10.00 per Private Unit for an aggregate purchase price of $11,500,000. Each Private Unit consists of one share of common stock and one warrant ("Private Warrant"). Each Private Warrant entitles the holder to purchase one share of common stock at an exercise price of $11.50. The proceeds from the sale of the Private Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Warrants will expire worthless. Additionally, the holders have agreed not to transfer, assign or sell any of the Private Units or underlying securities (except to certain permitted transferees and provided the transferees agree to the same terms and restrictions as the permitted transferees of the insider shares must agree to) until after the completion of a Business Combination. |
Related Party Transactions
Related Party Transactions | 6 Months Ended |
Jun. 30, 2019 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Insider Shares In March 2016, the Company issued 3,737,500 shares of common stock to the initial stockholders (the "insider shares") for an aggregate purchase price of $25,000. In February 2018, the Company sold an additional 1,293,750 insider shares for an aggregate purchase price of $8,654, resulting in a total of 5,031,250 insider shares issued and outstanding. The 5,031,250 insider shares included an aggregate of up to 656,250 shares subject to forfeiture by the initial stockholders to the extent that the underwriter's over-allotment was not exercised in full or in part, so that the initial stockholders would collectively own 20% of the Company's issued and outstanding shares after the Initial Public Offering, excluding shares in the Private Units (assuming the initial stockholders did not purchase any Public Shares in the Initial Public Offering). On June 5, 2018, as a result of the underwriters' election to exercise their over-allotment option in full, 656,250 insider shares are no longer subject to forfeiture. The initial stockholders have agreed not to transfer, assign or sell any of the insider shares (except to certain permitted transferees) with respect to 50% of the insider shares, until the earlier of (i) six months after the date of the consummation of a Business Combination and on the date on which the closing price of the Company's common stock equals or exceeds $12.50 per share for any 20 trading days within any 30-trading day period following the consummation of a Business Combination and, with respect to the remaining 50% of the insider shares, six months after the date of the consummation of a Business Combination, or if, (ii) subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their common stock for cash, securities or other property (the "Lock-Up Period"). Promissory Notes — Related Parties In March 2016, VK Consulting loaned the Company $425,000 to be used for the payment of costs related to the Initial Public Offering. On February 15, 2018, the terms of the promissory note with VK Consulting were amended such that the loan is now payable upon the consummation of a Business Combination. Administrative Services Agreement The Company entered into an agreement whereby, commencing on May 30, 2018 through the earlier of the Company's consummation of a Business Combination and its liquidation, the Company will pay VK Consulting a monthly fee of $7,500 for office space and secretarial and administrative services. For the three months ended June 30, 2019 and 2018, the Company paid $22,500 and $7,500 in fees for these services, respectively. For the six months ended June 30, 2019 and 2018, the Company paid $45,000 and $7,500 in fees for these services, respectively. Related Party Loans In order to finance transaction costs in connection with a Business Combination, certain of the Company's initial stockholders, officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans"). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds held in the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Up to $200,000 of Working Capital Loans may be convertible into Private Units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. Such Units would be identical to the Private Units. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 6. COMMITMENTS AND CONTINGENCIES Registration Rights Pursuant to a registration rights agreement entered into on May 29, 2018, the holders of the insider shares, as well as the holders of the Private Units (and any shares of common stock issuable upon exercise of the Private Warrants) and any shares the initial stockholders, officers, directors or their affiliates may be issued in payment of the Working Capital Loans, are entitled to registration rights. The holders of the majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Units or units issued in payment of Working Capital Loans made to the Company can elect to exercise these registration rights at any time commencing on the date that the Company consummates a Business Combination. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriter is entitled to a deferred fee of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $5,031,250. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement. Warrant Solicitation Fee The Company has agreed to pay the underwriter a warrant solicitation fee of five percent (5%) of the exercise price of each Public Warrant exercised during the period commencing twelve months after the effective date of the Initial Public Offering, including warrants acquired by security holders in the open market, but excluding warrants exercised during the 30 day period following notice of a proposed redemption. The warrant solicitation fee will be payable in cash. There is no limitation on the maximum warrant solicitation fee payable to the underwriter, except to the extent it is limited by the number of Public Warrants outstanding. |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Jun. 30, 2019 | |
Equity [Abstract] | |
STOCKHOLDERS' EQUITY | NOTE 7. STOCKHOLDERS' EQUITY Preferred Stock — Common Stock Warrants The Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days' prior written notice of redemption; ● if, and only if, the last sale price of the Company's common stock equals or exceeds $16.00 per share for any 20 trading days within a 30-trading day period ending on a the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and ● If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a "cashless basis," as described in the warrant agreement. The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants are non-redeemable so long as they are held by the initial purchasers or such purchasers' permitted transferees. If the Private Warrants are held by holders other than the initial purchasers or any of their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants stock. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company's assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. Unit Purchase Option On June 1, 2018, the Company sold to the underwriter (and its designees), for $100, an option to purchase up to a total of 1,750,000 Units exercisable at $12.00 per Unit (or an aggregate exercise price of $21,000,000) commencing on the later of November 29, 2018 and the consummation of a Business Combination. The option represents the right to purchase 1,750,000 shares of common stock and 1,750,000 warrants to purchase 1,750,000 shares of common stock. The unit purchase option may be exercised for cash or on a cashless basis, at the holder's option, and expires on May 29, 2023. The Units issuable upon exercise of this option are identical to those offered in the Initial Public Offering. The Company accounted for the unit purchase option, inclusive of the receipt of $100 cash payment, as an expense of the Initial Public Offering resulting in a charge directly to stockholders' equity. The Company determined the fair value of this unit purchase option to be approximately $5,048,518 (or $2.88 per Unit) using the Black-Scholes option-pricing model. The fair value of the unit purchase option granted to the underwriter was estimated as of the date of grant using the following assumptions: (1) expected volatility of 35%, (2) risk-free interest rate of 2.74% and (3) expected life of five years. The option and the 1,750,000 Units, as well as the 1,750,000 shares of common stock and 1,750,000 warrants, and 1,750,000 shares of common stock underlying such warrants, that may be issued upon exercise of the option, have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA's NASD Conduct Rules. Additionally, the option may not be sold, transferred, assigned, pledged or hypothecated for 180 days following the effective date of Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners, nor may the option, nor the securities underlying the option, be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition for such period. The option grants to holders demand and "piggyback" rights for periods of five and seven years, respectively, from the effective date of the registration statement with respect to the registration under the Securities Act of the securities directly and indirectly issuable upon exercise of the option. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise price and number of units issuable upon exercise of the option may be adjusted in certain circumstances including in the event of a share dividend, or the Company's recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of common stock at a price below its exercise price. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jun. 30, 2019 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENTS | NOTE 8. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company's financial assets and liabilities reflects management's estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company's assets that are measured at fair value on a recurring basis at June 30, 2019 and December 31, 2018, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level June 30, December 31, Assets: Marketable securities held in Trust Account 1 $ 209,878,786 $ 207,753,062 |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2019 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 9. SUBSEQUENT EVENTS The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements were issued. Based upon the review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jun. 30, 2019 | |
Accounting Policies [Abstract] | |
Basis of presentation | Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the SEC on March 27, 2019, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2018 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The interim results for the three and six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019 or for any future interim periods. |
Principles of Consolidation | Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiary where the Company has the ability to exercise control. All significant intercompany balances and transactions have been eliminated in consolidation. Activities in relation to the noncontrolling interest are not considered to be significant and are, therefore, not presented in the accompanying condensed consolidated financial statements. |
Emerging growth company | Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s balance sheet with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of estimates | Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and cash equivalents | Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2019 and December 31, 2018. |
Cash held in escrow | Cash held in escrow At May 7, 2019, the Company placed $386,030 into an escrow account maintained by the Company’s legal counsel (the “Escrowed Amount”). The Escrowed Amount is being held in a non-interest bearing account, is under the Company’s full control and will be released upon written instruction from the Company. As of June 30, 2019, $386,030 of cash remained in the escrow account. |
Marketable securities held in Trust Account | Marketable securities held in Trust Account At June 30, 2019 and December 31, 2018, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. During the six months ended June 30, 2019, the Company withdrew $505,155 of interest earned on the Trust Account to pay its franchise and income tax obligations. |
Common stock subject to possible redemption | Common stock subject to possible redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed consolidated balance sheets. |
Income taxes | Income taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2019 and December 31, 2018, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company may be subject to potential examination by federal or state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. |
Net loss per common share | Net loss per common share Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and private placement to purchase 21,275,000 shares of common stock and (2) 1,750,000 shares of common stock and warrants to purchase 1,750,000 shares of common stock in the unit purchase option sold to the underwriters and their designees, in the calculation of diluted loss per share, since the exercise of the warrants and the exercise of the unit purchase option is contingent upon the occurrence of future events. As a result, diluted loss per common share is the same as basic loss per common share for the periods. |
Reconciliation of net loss per common share | Reconciliation of net loss per common share The Company's net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: Three Months Ended June 30, Six Months Ended June 30, 2019 2018 2019 2018 Net income $ 827,477 $ 97,885 $ 1,622,292 $ 93,157 Less: Income attributable to shares subject to redemption (1,057,670 ) (194,672 ) (1,983,743 ) (194,672 ) Adjusted net loss $ (230,193 ) $ (96,787 ) $ (361,451 ) $ (101,515 ) Weighted average common shares outstanding, basic and diluted 7,083,746 5,191,749 7,077,223 4,449,995 Basic and diluted net loss per common share $ (0.03 ) $ (0.02 ) $ (0.05 ) $ (0.02 ) |
Concentration of credit risk | Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal depository insurance coverage of $250,000. At June 30, 2019 and December 31, 2018, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Fair value of financial instruments | Fair value of financial instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature. |
Recently issued accounting standards | Recently issued accounting standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Accounting Policies [Abstract] | |
Schedule of basic and diluted loss per common share | Three Months Ended June 30, Six Months Ended June 30, 2019 2018 2019 2018 Net income $ 827,477 $ 97,885 $ 1,622,292 $ 93,157 Less: Income attributable to shares subject to redemption (1,057,670 ) (194,672 ) (1,983,743 ) (194,672 ) Adjusted net loss $ (230,193 ) $ (96,787 ) $ (361,451 ) $ (101,515 ) Weighted average common shares outstanding, basic and diluted 7,083,746 5,191,749 7,077,223 4,449,995 Basic and diluted net loss per common share $ (0.03 ) $ (0.02 ) $ (0.05 ) $ (0.02 ) |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jun. 30, 2019 | |
Fair Value Disclosures [Abstract] | |
Schedule of fair value on a recurring basis | Description Level June 30, December 31, Assets: Marketable securities held in Trust Account 1 $ 209,878,786 $ 207,753,062 |
Description of Organization a_2
Description of Organization and Business Operations (Details) - USD ($) | Jun. 05, 2018 | Jun. 01, 2018 | Jun. 30, 2019 |
Description of Organization and Business Operations (Textual) | |||
Unit price | $ 10 | $ 10.20 | |
Net proceeds from issuance equity held in trust account | $ 1,181,250 | ||
Proceeds in trust account | 26,775,000 | ||
Total net proceeds held in the trust account | 205,275,000 | ||
Transaction costs | 11,101,864 | ||
Underwriting fees | 5,031,250 | ||
Deferred underwriting fees | 5,031,250 | ||
Other costs | $ 1,039,364 | ||
Working Capital | $ 351,228 | ||
Minimum percentage of trust account required for business combination | 80.00% | ||
Percentage of outstanding voting securities | 50.00% | ||
Description of business combination within the combination period | The Company will have until December 1, 2019 to consummate a Business Combination (the "Combination Period"). If the Company is unable to consummate a Business Combination within the Combination Period , the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders' rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company's board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. | ||
Net tangible assets | $ 5,000,001 | ||
Description of restricted stock | The Company's Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), will be restricted from converting its shares with respect to more than an aggregate of 20% of the shares sold in the Initial Public Offering ("Excess Shares"). | ||
Percentage of redemption of company's outstanding public shares | 100.00% | ||
Underwriters [Member] | |||
Description of Organization and Business Operations (Textual) | |||
Number of units issued in transaction | 1,750,000 | ||
Gross proceeds from issuance offering | $ 21,000,000 | $ 5,031,250 | |
Unit price | $ 12 | ||
Over-allotment option [Member] | Underwriters [Member] | |||
Description of Organization and Business Operations (Textual) | |||
Number of units issued in transaction | 26,250,000 | 2,625,000 | |
Gross proceeds from issuance offering | $ 26,250,000 | ||
Initial Public Offering [Member] | |||
Description of Organization and Business Operations (Textual) | |||
Number of units issued in transaction | 17,500,000 | 20,125,000 | |
Gross proceeds from issuance offering | $ 175,000,000 | ||
Unit price | $ 10.20 | $ 10 | |
Net proceeds from issuance equity held in trust account | $ 178,500,000 | ||
Private Placement [Member] | |||
Description of Organization and Business Operations (Textual) | |||
Number of units issued in transaction | 1,150,000 | 1,150,000 | |
Gross proceeds from issuance offering | $ 11,500,000 | $ 11,500,000 | |
Unit price | $ 10 | $ 10 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 | ||
Accounting Policies [Abstract] | |||||
Net income (loss) | $ 827,477 | $ 97,885 | $ 1,622,292 | $ 93,157 | |
Less: Income attributable to shares subject to redemption | (1,057,670) | (194,672) | (1,983,743) | (194,672) | |
Adjusted net loss | $ (230,193) | $ (96,787) | $ (361,451) | $ (101,515) | |
Weighted average common shares outstanding, basic and diluted | [1] | 7,083,746 | 5,191,749 | 7,077,223 | 4,449,995 |
Basic and diluted net loss per common share | [2] | $ (0.03) | $ (0.02) | $ (0.05) | $ (0.02) |
[1] | Excludes an aggregate of 19,193,198 and 19,272,344 shares subject to redemption, at June 30, 2019 and 2018, respectively. | ||||
[2] | Net loss per share - basic and diluted excludes income attributable to common stock subject to possible redemption of $1,057,670, and $194,672 for the three months ended June 30, 2019 and 2018, respectively, and $1,983,743 and $194,672 for the six months ended June 30, 2019 and 2018, respectively. |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Details Textual) - USD ($) | Jun. 01, 2018 | Jun. 30, 2019 | May 07, 2019 |
Summary of Significant Accounting Policies (Textual) | |||
Cash held in escrow | $ 386,030 | $ 386,030 | |
Withdrew of interest earned on trust account | 505,155 | ||
Federal depository insurance coverage | $ 250,000 | ||
Private Placement [Member] | |||
Summary of Significant Accounting Policies (Textual) | |||
Number of units issued in transaction | 1,150,000 | 1,150,000 | |
Underwriters [Member] | |||
Summary of Significant Accounting Policies (Textual) | |||
Number of units issued in transaction | 1,750,000 | ||
Warrant [Member] | Underwriters [Member] | |||
Summary of Significant Accounting Policies (Textual) | |||
Number of units issued in transaction | 1,750,000 | ||
Common Stock [Member] | Private Placement [Member] | |||
Summary of Significant Accounting Policies (Textual) | |||
Number of units issued in transaction | 21,275,000 | ||
Common Stock [Member] | Underwriters [Member] | |||
Summary of Significant Accounting Policies (Textual) | |||
Number of units issued in transaction | 1,750,000 |
Initial Public Offering (Detail
Initial Public Offering (Details) - $ / shares | Jun. 05, 2018 | Jun. 01, 2018 | Jun. 30, 2019 |
Unit price | $ 10 | $ 10.20 | |
Warrant [Member] | |||
Unit price | $ 11.50 | ||
Underwriters [Member] | |||
Number of units issued in transaction | 1,750,000 | ||
Unit price | $ 12 | ||
Underwriters [Member] | Warrant [Member] | |||
Number of units issued in transaction | 1,750,000 | ||
Initial Public Offering [Member] | |||
Number of units issued in transaction | 17,500,000 | 20,125,000 | |
Unit price | $ 10.20 | $ 10 | |
Over-allotment option [Member] | Underwriters [Member] | |||
Number of units issued in transaction | 26,250,000 | 2,625,000 |
Private Placement (Details)
Private Placement (Details) - USD ($) | Jun. 01, 2018 | Jun. 30, 2019 | Jun. 05, 2018 |
Private Placement (Textual) | |||
Unit price | $ 10.20 | $ 10 | |
Private Placement [Member] | |||
Private Placement (Textual) | |||
Unit price | $ 10 | $ 10 | |
Number of units issued in transaction | 1,150,000 | 1,150,000 | |
Gross proceeds from issuance offering | $ 11,500,000 | $ 11,500,000 | |
Warrant [Member] | |||
Private Placement (Textual) | |||
Unit price | $ 11.50 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | Jun. 05, 2018 | Jun. 01, 2018 | May 30, 2018 | Feb. 28, 2018 | Mar. 31, 2016 | Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 |
Related Party Transactions (Textual) | |||||||||
VK Consulting loaned | $ 425,000 | ||||||||
Private Placement [Member] | |||||||||
Related Party Transactions (Textual) | |||||||||
Number of common stock issued | 1,150,000 | 1,150,000 | |||||||
Amount of debt converted | $ 200,000 | ||||||||
Conversion price (in dollars per share) | $ 10 | $ 10 | |||||||
Over-allotment option [Member] | |||||||||
Related Party Transactions (Textual) | |||||||||
Maximum shares subject to forfeited | 656,250 | ||||||||
Initial stockholders (the "insider shares") [Member] | |||||||||
Related Party Transactions (Textual) | |||||||||
Number of common stock issued | 3,737,500 | ||||||||
Purchase price of shares issued | $ 25,000 | ||||||||
Number of common stock sold | 1,293,750 | ||||||||
Purchase price of shares sold | $ 8,654 | ||||||||
Maximum shares subject to forfeited | 656,250 | ||||||||
Percentage of issued and outstanding shares | 20.00% | ||||||||
Description of initial stockholders | The initial stockholders have agreed not to transfer, assign or sell any of the insider shares (except to certain permitted transferees) with respect to 50% of the insider shares, until the earlier of (i) six months after the date of the consummation of a Business Combination and on the date on which the closing price of the Company's common stock equals or exceeds $12.50 per share for any 20 trading days within any 30-trading day period following the consummation of a Business Combination and, with respect to the remaining 50% of the insider shares, six months after the date of the consummation of a Business Combination, or if, (ii) subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their common stock for cash, securities or other property (the "Lock-Up Period"). | ||||||||
Total number shares issued and outstanding | 5,031,250 | ||||||||
Administrative Services Agreement [Member] | |||||||||
Related Party Transactions (Textual) | |||||||||
Payment for secretarial administrative fees | $ 22,500 | $ 7,500 | $ 45,000 | $ 7,500 | |||||
Fee for office space, secretarial & administrative services (monthly) | $ 7,500 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - Underwriters [Member] - USD ($) | Jun. 01, 2018 | Jun. 30, 2019 |
Commitments and Contingencies (Textual) | ||
Deferred fee | 2.50% | |
Gross proceeds from offering | $ 21,000,000 | $ 5,031,250 |
Description of warrant solicitation Fee | The Company has agreed to pay the underwriter a warrant solicitation fee of five percent (5%) of the exercise price of each Public Warrant exercised during the period commencing twelve months after the effective date of the Initial Public Offering, including warrants acquired by security holders in the open market, but excluding warrants exercised during the 30 day period following notice of a proposed redemption. |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) | Jun. 01, 2018 | Jun. 30, 2019 | Dec. 31, 2018 | Jun. 05, 2018 | May 29, 2018 |
Stockholders' Equity (Textual) | |||||
Preferred stock, par value | $ 0.001 | $ 0.001 | |||
Preferred stock, authorized | 1,000,000 | 1,000,000 | |||
Common stock, par value | $ 0.001 | $ 0.001 | |||
Common stock, authorized | 100,000,000 | 100,000,000 | |||
Common stock, issued | 7,113,052 | 7,070,627 | |||
Common stock, outstanding | 7,113,052 | 7,070,627 | |||
Description of warrant redemption | The Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; ● if, and only if, the last sale price of the Company’s common stock equals or exceeds $16.00 per share for any 20 trading days within a 30-trading day period ending on a the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and ● If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. | ||||
Unit price | $ 10.20 | $ 10 | |||
Common stock subject to possible redemption | 19,193,198 | 19,235,623 | |||
Warrant [Member] | |||||
Stockholders' Equity (Textual) | |||||
Unit price | $ 11.50 | ||||
Description of option | The option and the 1,750,000 Units, as well as the 1,750,000 shares of common stock and 1,750,000 warrants, and 1,750,000 shares of common stock underlying such warrants, that may be issued upon exercise of the option, have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA's NASD Conduct Rules. | ||||
Underwriters [Member] | |||||
Stockholders' Equity (Textual) | |||||
Preferred stock, par value | $ 0.001 | ||||
Preferred stock, authorized | 1,000,000 | ||||
Common stock, par value | $ 0.001 | ||||
Common stock, authorized | 100,000,000 | ||||
Transaction amount | $ 100 | ||||
Number of unit issued in transaction | 1,750,000 | ||||
Gross proceeds from issuance offering | $ 21,000,000 | $ 5,031,250 | |||
Unit price | $ 12 | ||||
Estimated fair value of option | $ 5,048,518 | ||||
Fair value per unit | $ 2.88 | ||||
Expected volatility rate | 35.00% | ||||
Risk free interest rate | 2.74% | ||||
Expected term | 5 years | ||||
Description of option | The option represents the right to purchase 1,750,000 shares of common stock and 1,750,000 warrants to purchase 1,750,000 shares of common stock. | ||||
Underwriters [Member] | Warrant [Member] | |||||
Stockholders' Equity (Textual) | |||||
Number of unit issued in transaction | 1,750,000 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) | Jun. 30, 2019 | Dec. 31, 2018 |
Assets: | ||
Marketable securities held in Trust Account | $ 209,878,786 | $ 207,753,062 |
Level 1 [Member] | ||
Assets: | ||
Marketable securities held in Trust Account | $ 209,878,786 | $ 207,753,062 |